Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
TARA Stock — Protara Therapeutics Inc
Protara Therapeutics Inc (TARA)
Updated October 16, 2026.
TARA is a Stock. Total return is -99.4% over the past 12 years, 482.8 points behind SPY at 383.4%.
Protara Therapeutics is a clinical-stage biopharmaceutical company developing transformative therapies for cancer and rare diseases, with its lead program being TARA-002, an investigational cell therapy in Phase II trials for non-muscle invasive bladder cancer and lymphatic malformations, alongside an intravenous choline chloride therapy for patients on parenteral nutrition. The company does not currently distribute to shareholders. Protara appeals to investors seeking exposure to early-stage biotech development rather than current income.
TARA dividend yield and income
Price as of 2026-10-16.
The payment date is 01/10/2020.
TARA performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.4% over the past 12 years, 482.8 points behind SPY at 383.4%. Over the past year its total return — price change plus distributions reinvested — is -59.9%. Its deepest 1-year drawdown was 69.3%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -35.9% | — |
| 3M | -43.1% | — |
| 6M | -54.8% | — |
| YTD | -56.5% | — |
| 1Y | -59.9% | — |
| 2Y CAGR | — | 11.70% |
| 3Y CAGR | — | 10.30% |
| 5Y CAGR | — | -19.40% |
| 10Y CAGR | — | -39.50% |
| Since inception (12 years) | -99.4% | -34.90% |
TARA key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 10/22/2014
- Distribution frequency
- None
- Last close
- $2.32 (as of 2026-10-16)
- Market cap
- $137,101,532
- Average volume
- 1157261.0
- Payment date
- 01/10/2020
- Beta
- 1.465
- Payout ratio
- 0.0%
- EPS
- $-1.36
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
TARA risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 69.3%.
Who may consider TARA — and who may not
It is a weaker fit for investors who need monthly cash flow (TARA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on TARA
Frequently asked questions
Does TARA pay monthly?
No. TARA does not currently distribute.
When does TARA pay a dividend?
TARA does not currently distribute. The payment date is 01/10/2020.
How has TARA performed?
Total return is -99.4% over the past 12 years, 482.8 points behind SPY at 383.4%. Over the past year its total return — price change plus distributions reinvested — is -59.9%. Its deepest 1-year drawdown was 69.3%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.